Dr. Freese has practiced veterinary medicine for more than 40 years in Southwest Minnesota, and is the co-owner of the Veterinary Medical Center, a large mixed animal practice based in Worthington, MN. He co-founded both Oxford Laboratories (now owned by Merck) and Newport Laboratories (now owned by Merial).
Dr. Freese has served as a consulting veterinarian in Europe, Asia, Mexico, and Canada. He is a past President of the American Association of Swine Practitioners and the Interstate Veterinary Medical Association. He has served as a bank director and held positions on several economic planning committees in Southwest Minnesota. In his spare time, Dr. Freese enjoys fishing and hunting.
Dr. Simonson began his career as a scientist for Salsbury Laboratories, becoming the Manager of Biological Development. He served as Manager of Biologic Development for Solvay before moving to Oxford Laboratories, first as Team Manager, licensing the original swine biologics line for the company and later becoming Vice President of Research and Development. After Oxford was purchased by The Upjohn Company, he became the Director of Biological Development Worldwide. Following the purchase of Upjohn by Bayer, he advanced to Director of Biologics Project Management Worldwide.
Dr. Simonson comes to Cambridge Technologies from Newport Laboratories where he was the Chief Operating Officer and later President. He has authored numerous publications and patents regarding biologic research and product applications, and is often requested as a speaker and presenter at both domestic and international technical meetings.